Do‐Hyun Nam

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E. Hegi, Thierry Gorlia et al. · The Lancet Oncology · 2014 · 1K citations

Neuro-oncology, Glioma, Medicine +9

Development of a <i>T</i>₁ Contrast Agent for Magnetic Resonance Imaging Using MnO Nanoparticles

Hyon Bin Na, Jung Hee Lee, Kwangjin An et al. · Angewandte Chemie International Edition · 2007 · 601 citations

Nanoparticles, Engineering, Imaging Agent +16

Clinical practice guidelines for the management of adult diffuse gliomas

Tao Jiang, Do‐Hyun Nam, Zvi Ram et al. · Cancer Letters · 2020 · 454 citations

Neuro-oncology, Glioma, Medicine +10

Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors

Marat S. Pavlyukov, Hai Yu, Soniya Bastola et al. · Cancer Cell · 2018 · 312 citations · Full text

Neuro-oncology, Glioma, Splicing Factors +6

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

Jin‐Ku Lee, Zhaoqi Liu, K. Jason et al. · Nature Genetics · 2018 · 203 citations · Full text

Tumor Biology, Tumor Heterogeneity, Medicine +9